Moreover, tirzepatide outperformed semaglutide when it came to weight loss, with tirzepatide doses of 15 mg, 10 mg, and 5 mg delivering notable reductions in body weight (-10.96 Kg, -8.75 Kg, and -6.16 Kg, respectively) compared to semaglutide (-5.24 Kg, -4.44 Kg, and -2.72 Kg for semaglutide at 2.0, 1.0, and 0.5 mg, respectively)
Though these medications are not currently FDA-approved for PCOS, a couple studies have found that in people with the condition who also have a higher weight, the drugs dont just have a weight-loss effect but can also alleviate PCOS-specific symptoms like cycle abnormalities
In addition, he is a frequent lecturer at symposia sponsored by institutions such as the World Bank and IMF, Columbia University, Scripps Institute, New York University, and Harvard University and serves as an Associate Professor at the University of Miami Miller School of Medicine
Vale W, Rivier C, Brazeau P, Guillemin R
10.1016/S0002-9440(10)63877-1 4 BaiT.LiangB.ZhaoY.HanJ.PuY.WangC.et al (2022)
Consider the example of the stomach